Skip to content

Effect of bitter almond oil in treatment of knee arthrosis

Comparison of the effectiveness of Amygdalus communis var. amara oil with placebo, diclofenac and massage in improving joint pain and stiffness and physical function in knee osteoarthritis patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170821035817N1
Enrollment
200
Registered
2017-12-17
Start date
2018-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis. Arthrosis, unspecified

Interventions

Intervention 1: Fifty patients apply topical bitter almond oil to the knee every 8 hours for 10 minutes during 1 month. Intervention 2: Fifty patients apply topical diclofenac to the knee every 8 hour
Treatment - Drugs
Treatment - Other
Placebo
Fifty patients apply topical bitter almond oil to the knee every 8 hours for 10 minutes during 1 month
Fifty patients apply topical diclofenac to the knee every 8 hours for 10 minutes during 1 month
Fifty patients massage the knee without application of any topical agent every 8 hours for 10 minutes during 1 month
Fifty patients apply topical placebo to the knee every 8 hours for 10 minutes during 1 month

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor
Iranian academic center for education culture and research
Collaborator

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: Male or female patients with 1 or 2 knees osteoarthritis according to the American College of Rheumatology criteria after physical examination and knee joint radiography Age of 40 to 85 years Flare of the disease after oral non-steroidal anti-inflammatory drug or acetaminophen discontinuation which have been used at least 3 days a week during the past month (flare means increase of at least 2 scores in the total pain subscale score in the beginning of the study.) Western Ontario and McMaster Universities (WOMAC) pain subscale index at least 9 out of 20 in the beginning of the study

Exclusion criteria

Exclusion criteria: Secondary osteoarthritis (due to a definite disease) Arthroscopy Knee surgery History of knee replacement surgery Infection Cardiovascular disease Hepatic disease Renal disease Other chronic inflammatory disease History of alcohol abuse History of drug abuse History of narcotic abuse Skin disease in the knee area Fibromyalgia Debilitating disease affecting the knee Pregnant women Women planning pregnancy Lactating women

Design outcomes

Primary

MeasureTime frame
Extent of arthritis. Timepoint: Before intervention and 1 month after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index questionnaire.

Secondary

MeasureTime frame
Extent of joint stiffness. Timepoint: Before intervention and 1 month after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index questionnaire.;Extent of joint pain. Timepoint: Before intervention and 1 month after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index questionnaire.;Extent of physical function. Timepoint: Before intervention and 1 month after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Saeed Kianbakht

ACECR Institute of Medicinal Plants

kianbakht@imp.ac.ir+98 26347640109

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026